Acquired
Novo Nordisk (Ozempic)
David Rosenthal
There are a number of analogies that we could make from the past few years that I'll refrain from here. So as you say, is this a nail in the coffin for Novo? You know, I mean, it's not good for the underlying business. Nordisk, meanwhile, remember, they're in the midst of this aggressive expansion plan and scaling based on MC insulin.
0
💬
0
Comments
Log in to comment.
There are no comments yet.